Palmer I, Clarke S A, Buchanan F J
School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, UK.
School of Nursing and Midwifery, Medical Biology Centre, Queen's University Belfast, Belfast, UK.
Bone Joint Res. 2019 Jul 5;8(6):266-274. doi: 10.1302/2046-3758.86.BJR-2018-0224.R2. eCollection 2019 Jun.
Bioresorbable orthopaedic devices with calcium phosphate (CaP) fillers are commercially available on the assumption that increased calcium (Ca) locally drives new bone formation, but the clinical benefits are unknown. Electron beam (EB) irradiation of polymer devices has been shown to enhance the release of Ca. The aims of this study were to: 1) establish the biological safety of EB surface-modified bioresorbable devices; 2) test the release kinetics of CaP from a polymer device; and 3) establish any subsequent beneficial effects on bone repair .
ActivaScrew Interference (Bioretec Ltd, Tampere, Finland) and poly(L-lactide-co-glycolide) (PLGA) orthopaedic screws containing 10 wt% β-tricalcium phosphate (β-TCP) underwent EB treatment. degradation over 36 weeks was investigated by recording mass loss, pH change, and Ca release. Implant performance was investigated over 36 weeks using a lapine femoral condyle model. Bone growth and osteoclast activity were assessed by histology and enzyme histochemistry.
Calcium release doubled in the EB-treated group before returning to a level seen in untreated samples at 28 weeks. Extensive bone growth was observed around the perimeter of all implant types, along with limited osteoclastic activity. No statistically significant differences between comparative groups was identified.
The higher than normal dose of EB used for surface modification did not adversely affect tissue response around implants . Surprisingly, incorporation of β-TCP and the subsequent accelerated release of Ca had no significant effect on implant performance, calling into question the clinical evidence base for these commercially available devices.: I. Palmer, S. A. Clarke, F. J Buchanan. Enhanced release of calcium phosphate additives from bioresorbable orthopaedic devices using irradiation technology is non-beneficial in a rabbit model: An animal study. 2019;8:266-274. DOI: 10.1302/2046-3758.86.BJR-2018-0224.R2.
含磷酸钙(CaP)填料的生物可吸收骨科器械已上市,其依据是局部钙(Ca)增加可促进新骨形成,但临床益处尚不清楚。已证明电子束(EB)辐照聚合物器械可增强钙的释放。本研究的目的是:1)确定经EB表面改性的生物可吸收器械的生物安全性;2)测试聚合物器械中CaP的释放动力学;3)确定对骨修复的任何后续有益作用。
对ActivaScrew干涉钉(芬兰坦佩雷Bioretec有限公司)和含10 wt%β-磷酸三钙(β-TCP)的聚(L-丙交酯-共-乙交酯)(PLGA)骨科螺钉进行EB处理。通过记录质量损失、pH变化和钙释放来研究36周内的降解情况。使用兔股骨髁模型在36周内研究植入物性能。通过组织学和酶组织化学评估骨生长和破骨细胞活性。
在28周恢复到未处理样品所见水平之前,EB处理组的钙释放量增加了一倍。在所有植入物类型的周边均观察到广泛的骨生长,同时破骨细胞活性有限。比较组之间未发现统计学上的显著差异。
用于表面改性的高于正常剂量的EB对植入物周围的组织反应没有不利影响。令人惊讶的是,β-TCP的加入以及随后钙的加速释放对植入物性能没有显著影响,这使这些市售器械的临床证据基础受到质疑。:I. 帕尔默,S.A. 克拉克,F.J. 布坎南。使用辐照技术增强生物可吸收骨科器械中磷酸钙添加剂的释放对兔模型无益处:一项动物研究。2019;8:266 - 274。DOI:10.1302/2046 - 3758.86.BJR - 2018 - 0224.R2。